The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The North America analgesics market reached a value of US$ 21.8 Billion in 2020. An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. Analgesic drugs act in different ways on the peripheral and central nervous systems. They mostly include paracetamol or acetaminophen, the nonsteroidal anti-inflammatory drugs (NSAIDs), such as the salicylates, and opioid drugs, including morphine and oxycodone. Analgesics are taken to relieve pain that can arise from appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc.
The North America analgesics market is currently driven by several factors. The rising geriatric population suffering from incurable health issues, such as joint pain, has stimulated the demand for pain treatment therapies. These therapies employ different types of analgesics, thus catalyzing the market growth in the region. Moreover, the prevalence of osteoarthritis, cardiovascular diseases and cancer have substantially risen in the region, which has also induced the demand for analgesics. Furthermore, the growing number of surgeries, coupled with the penetration of effective pain management medications is expected to fuel the growth of the market during the next few years. Apart from this, availability of analgesics drugs in forms of gels, creams, sprays and oral tablets has made them consumer friendly. Looking forward, IMARC Group expects the North America analgesics market to exhibit stable growth during the next five years.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Drug Class, Route of Administration, Pain Type, Application, Country|
|Region Covered||United States, Canada, Mexico|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License $ 2499
Five User License $ 3499
Corporate License $ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
Report Customization: Although IMARC has tried to cover everything in the North America analgesics market landscape, we believe that every stakeholder may have their own specific needs. In view of this, we provide up to 20-man hours of free customization for each report.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at